• 5 Days of Stem Cells - a virtual event
A Virtual Event
5 Days of Stem Cells
Connect. Discover. Advance.
Join us for the world’s leading virtual stem cell event.
Photo

Donna Chang

Hope Biosciences

As the President and CEO of Hope Biosciences, Donna Chang is on a mission to revolutionize the field of cell therapy. She has over 12 years of experience in biotechnology business development, including business expansion and strategic partnering. Donna started her career in economic development in life sciences. She later transitioned into industry, focused entirely on cellular therapeutics. Her passion in this subject is the leading motivation to find solutions to the current limitations in cell therapy and deliver approved therapies to the market - quickly. Donna started Hope Biosciences in 2016 with a goal to develop and deliver adult stem cell therapeutics that are safe, effective and affordable. Hope Bio’s groundbreaking patented core cell culture technology has been utilized in over 12 groundbreaking clinical trials in the United States. The company anticipates to bring these therapies to market in the very near future. Donna graduated from the University of Toronto with a degree in Bioethics and Human Biology. She received her Masters (M.S.) in Biotechnology with a concentration in Enterprise Development from Johns Hopkins University. 


Optimization and Standardization in Stem Cell Manufacturing for the Fight Against COVID-19

Abstract

The pandemic has forced the drug development industry to move at an unprecedented pace. Cellular therapies are finally being looked at as a possibility for immunomodulation and tissue regeneration. However, the existing challenges and limitations in delivering these therapies, are coming to light. Since its inception, Hope Biosciences has been working on solutions to deliver high quality, standardized, fresh mesenchymal stem cells - on -demand. COVID-19 is putting our methods to the ultimate test and gives us a glimpse of what the future looks like.